摘要
目的:观察泛昔洛韦加用氯雷他定、复方青黛胶囊和复方樟脑乳膏联合治疗玫瑰糠疹的临床疗效。方法:68例玫瑰糠疹患者被随机均分为单用泛昔洛韦治疗组和加用氯雷他定、复方青黛胶囊和复方樟脑乳膏联合治疗组。对照组口服泛昔洛韦。联合治疗组在对照组的基础上口服氯雷他定和复方青黛胶囊;用复方樟脑乳膏搽患处。7 d为一个疗程,3个月后观察比较临床疗效。结果:治疗后联合治疗组患者的疗效明显好于对照组(P<0.05),并且未出现皮肤刺痒等并发症及明显的副作用。结论:泛昔洛韦、氯雷他定、复方青黛胶囊和复方樟脑乳膏联合治疗玫瑰糠疹,安全,无明显副作用,疗效明显优于单纯应用泛昔洛韦。
Objective： To observe the efficacy of combination therapy（famciclovir plus loratadine,compound qingdai capsule,and compound camphor cream） in treating pityriasis rosea.Methods： Altogether 68 patients with pityriasis rosea were randomly divided into two groups： a famciclovir group and a combination therapy group（n=34 in each group）.In the combination therapy group,patients orally took famciclovir,loratadine,and compound qingdai capsule.In addition,compound camphor cream was applied to the affected area.In the famciclovir group patients orally took famciclovir.A course of treatment was 7 days and the efficacy was evaluated after 3-month treatment.Results： The efficacy of the combination therapy group was significantly better than that of the famciclovir group（P0.05）.Compared with the famciclovir group,the patients in the combination therapy group showed less complications（such as skin itching） and side effects.Conclusion： The combination therapy with famciclovir,loratadine,compound qingdai capsule,and compound camphor cream is effective and safe in treating pityriasis rosea,which shows significant advantages over single application of famciclovir.
出处
《国际病理科学与临床杂志》
CAS
2012年第5期397-399,共3页
Journal of International Pathology and Clinical Medicine
关键词
泛昔洛韦
氯雷他定
玫瑰糠疹
复方青黛胶囊
复方樟脑乳膏
famciclovir
loratadine
pityriasis rosea
compound qingdai capsule
compound camphor cream
